东凌迪芙合用舒血宁治疗急性脑梗死临床疗效观察

目的:该文比较东凌迪芙合用舒血宁治疗急性脑梗死的临床疗效。方法:将60例急性脑梗死患者随机分两组,其中东凌迪芙和舒血宁治疗组30例(男19例,女11例),年龄40岁70岁(43.88.9),应用东凌迪芙10 BU静脉点滴。隔日1次,6 d为1疗程,舒血宁20 ml静脉点滴,15 d为1疗程。对照组30例(男17例,女13例),年龄40岁71岁(41.4±10.8),常规治疗。结果:东凌迪芙组患者治疗后效果优于对照组(P<0.01)。结论:东凌迪芙合用舒血宁治疗急性脑梗死具有较好的疗效。

Observation on the Effect of Batroxobin an Shuxuening in Treatment of Patients with Acute Cerebral Infarction

Objective To observe the efficacy of Batroxobin on treatmen of acute cerebral infarction.Mrthods 60 patients with acute cerebral infarction were randomlydividedintotwogrounps batroxobin grounp(n=30)(M19,F11)age(43.8～8.9)was treated intravenously with Batroxobin in a daily dose of 10 BU for 6 days control group with control group a daily dose of 20ml for 15 days. Results There was stron ly significant difference(P<0.01).Conclusions Batroxobin is an effective drng superior to confrol gronp for decreasing nerve function deficiency and for improving living ability in patients with acute cerebral infarction.